Rating History for Janux Therapeutics (JANX) by UBS

More Stocks Rated by UBS | Latest Ratings for JANX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/15/2026 David Dai Downgrade Neutral
(Buy)		 15.00
(57.00)		 14.90
(14.91)		 0.07% Details